ICM
OFIX icon

Invenomic Capital Management’s Orthofix Medical OFIX Stock Holding History

Invenomic Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-153,477
Closed -$2.93M – 160
2022
Q3 		$2.93M Buy
153,477
+990
+0.6% +$22.3K 0.25% 103
2022
Q2 		$3.59M Buy
+152,487
New +$4.37M 0.25% 97

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Segall Bryant & Hamill
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Invenomic Capital Management's OFIX Position: Q4 2022 in Review

Invenomic Capital Management sold out of Orthofix Medical (OFIX) in Q4 2022, closing a stake of 153,477 shares — an estimated $2.93M sold.

Invenomic Capital Management first reported a position in OFIX in Q2 2022 and held it in 2 quarters. The position peaked at $3.59M in Q2 2022. 153 funds tracked by Wall St. Rank hold OFIX as of Q4 2022.

  • Invenomic Capital Management reported no remaining Orthofix Medical position as of Q4 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 153,477 Orthofix Medical shares in Q4 2022, an estimated $2.93M.
  • Invenomic Capital Management first reported a position in Orthofix Medical in Q2 2022 and held it in 2 quarters.
  • Invenomic Capital Management's Orthofix Medical position peaked at $3.59M in Q2 2022.
  • 153 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.